Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
NCT00039910
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
240
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-Hodgkin Lymphoma
Hodgkin Disease
Thrombocytopenia
Interventions
DRUG:
(PN-152,243)/ PN-196,444
Sponsor
Pfizer